Hydrogenology
Hydrogenology editorial study record

The effect of hydrogen-rich water consumption on premenstrual symptoms and quality of life: a randomized controlled trial

Aker MN et al. · BMC Womens Health. 2024;24:197.

HumanH₂-rich waterPublished 2024
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Single-center stratified blocked randomized double-blind placebo-controlled parallel trial

Research topic

Women’s health

Administration classification

H₂-rich water

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

University nursing and midwifery students with premenstrual syndrome

Sample

72 randomized; 65 completed: H₂ water n=33 and placebo n=32

Duration

From approximately cycle day 16 through day 2 of the next cycle, repeated for 3 menstrual cycles

Intervention

Freshly generated hydrogen-rich water, 1.5–2.0 L/day during the late luteal and early menstrual phase

Hydrogen form

H₂ dissolved in water — H₂ only, not Brown’s gas.

H₂ specification

A 500 mL generator was run for 5 minutes to reach saturation; the article does not report a numeric dissolved-H₂ concentration.

H₂ flow

Not applicable — oral water, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

The same bottled water placed in a visually similar non-hydrogen-generating flask

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Premenstrual Syndrome Scale and WHOQOL-BREF domains

Reported result

Premenstrual symptom scores favored H₂ water at both follow-ups. Some first-follow-up quality-of-life domains differed, but the overall group-by-time interaction for WHOQOL-BREF was not significant.

Results-extraction completeness

Intervention, full methods, results, registration, funding and conflict statements checked in the open-access publisher article.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Single-center student sample, questionnaire outcomes, seven randomized participants absent from the completed sample and no numeric dissolved-H₂ concentration. Public university funding was reported and authors declared no competing interests.

Applies directly to

University students with PMS meeting the study criteria; generalizability to other ages or clinical populations is uncertain.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 38532373 · DOI: 10.1186/s12905-024-03029-8

Publisher access

Open-access full text is available through PMC and the publisher.

Extraction basis

Open-access publisher and PMC full texts plus PubMed record.

Record revision

2026-08-10